Local Institution - 0020 — Nashville, Tennessee

Local Institution - 0020 is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Local Institution - 0020 has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer.

Sponsors: Mirati Therapeutics Inc., Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 0020?

Local Institution - 0020 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 0020 conducted?

Local Institution - 0020 has 2 clinical trials on record, with 1 currently active. Their work covers Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer.

Is Local Institution - 0020 accredited by Crixeo Health?

Local Institution - 0020 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 0020?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.